Huiping Jiang, Ph.D.

Dr. Jiang is a highly experienced professional in the pharmaceuticals and biotech industry with over 20 years working in multi-national pharmaceutical firms and biotech companies. She has been a member of the Qx board of directors since March 2020. She is currently the Chief Regulatory Officer at Valerio Therapeutics Inc. Prior to that role, she had served as Senior Vice President of Regulatory Affairs at Epizyme, Inc., a Cambridge MA based commercial-stage biotechnology company which pioneers innovative epigenetic drug development. Prior to that, she was at Boehringer Ingelheim Pharmaceuticals Inc. and AstraZeneca. Dr. Jiang brings to us drug development experience from early discovery to marketing authorization in both big pharma and small biotech settings. Dr. Jiang began her scientific career as a genetic engineering postdoctoral fellow in the Department of Biology at California Institute of Technology and is a well-published author on peer-reviewed publications. She received her B.S. in biochemistry from Nanjing University and her Ph.D. in cell and molecular biology from Clarkson University.